Brought to you by 
Entellus Medical raises $30mm via Series D financing
30 Nov 2009
Executive Summary
Entellus Medical (developing less invasive ENT devices) has raised $30mm in Series D money. New investor Essex Woodlands Health Ventures led (and contributes a board member) and was joined by current shareholders Split Rock Partners and SV Life Sciences. Entellus will use the funds to add members to its sales and customer support departments and to promote the FinESS chronic sinusitis treatment for use in the physician's office. The company is planning a 2010 US launch and preparing for international marketing.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Entellus Medical raises $30mm via Series D financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice